CStone Pharmaceuticals (HKG:2616) Chief Executive Officer Jianxin Yang acquired 2,269,500 Shares of the company in the open market, according to a Wednesday filing with the Hong Kong bourse.
The shares were bought in June, July, and on Oct. 18. The share purchase takes the CEO's stake to 5.44%.
The company's share prices were almost 2% down in recent trading.
Price (HKD): $1.77, Change: $-0.030, Percent Change: -1.67%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.